126 related articles for article (PubMed ID: 8089067)
1. Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro.
Karlowsky JA; Zhanel GG; Davidson RJ; Hoban DJ
J Antimicrob Chemother; 1994 May; 33(5):937-47. PubMed ID: 8089067
[TBL] [Abstract][Full Text] [Related]
2. Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa.
Karlowsky JA; Zhanel GG; Davidson RJ; Hoban DJ
Antimicrob Agents Chemother; 1994 May; 38(5):1165-8. PubMed ID: 8067757
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.
Zhanel GG; Karlowsky JA; Hoban DJ; Davidson RJ
Chemotherapy; 1991; 37(2):114-21. PubMed ID: 1903340
[TBL] [Abstract][Full Text] [Related]
4. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method.
Isaksson B; Nilsson L; Maller R; Sörén L
J Antimicrob Chemother; 1988 Jul; 22(1):23-33. PubMed ID: 3139614
[TBL] [Abstract][Full Text] [Related]
5. Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model.
den Hollander JG; Mouton JW; van Goor MP; Vleggaar FP; Verbrugh HA
Antimicrob Agents Chemother; 1996 Mar; 40(3):784-6. PubMed ID: 8851612
[TBL] [Abstract][Full Text] [Related]
6. Postantibiotic effect of aminoglycosides on staphylococci.
Isaksson B; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
[TBL] [Abstract][Full Text] [Related]
7. Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model.
Zhu ZY; Li RC
J Antimicrob Chemother; 1998 Jul; 42(1):61-5. PubMed ID: 9700529
[TBL] [Abstract][Full Text] [Related]
8. Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.
den Hollander JG; Fuursted K; Verbrugh HA; Mouton JW
Antimicrob Agents Chemother; 1998 Apr; 42(4):749-54. PubMed ID: 9559777
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
Tam VH; Ledesma KR; Vo G; Kabbara S; Lim TP; Nikolaou M
Antimicrob Agents Chemother; 2008 Nov; 52(11):3987-93. PubMed ID: 18725438
[TBL] [Abstract][Full Text] [Related]
10. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
Baltch AL; Smith RP; Ritz W
Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.
Karlowsky JA; Saunders MH; Harding GA; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 1996 Jun; 40(6):1387-93. PubMed ID: 8726006
[TBL] [Abstract][Full Text] [Related]
13. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
[TBL] [Abstract][Full Text] [Related]
14. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.
Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
Antimicrob Agents Chemother; 1996 Jan; 40(1):35-9. PubMed ID: 8787875
[TBL] [Abstract][Full Text] [Related]
15. Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem.
Majcherczyk PA; Kunz S; Hattenberger M; Vaxelaire J; Zak O; O'Reilly T
J Antimicrob Chemother; 1994 Oct; 34(4):485-505. PubMed ID: 7646646
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect.
Zhanel GG; Crampton J; Kim S; Nicolle LE; Davidson RJ; Hoban DJ
Chemotherapy; 1992; 38(6):388-94. PubMed ID: 1288962
[TBL] [Abstract][Full Text] [Related]
17. Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa.
Park MK; Muhvich KH; Myers RA; Marzella L
Antimicrob Agents Chemother; 1991 Apr; 35(4):691-5. PubMed ID: 1906262
[TBL] [Abstract][Full Text] [Related]
18. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Hybenová D; Majtán V
Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
[TBL] [Abstract][Full Text] [Related]
20. Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans.
Buxbaum A; Georgopoulos A
Infection; 1996; 24(6):459-64. PubMed ID: 9007594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]